![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol. , 30 November 2022
Sec. Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1049345
This article is part of the Research Topic Stem Cells in Pancreatic Cancer View all 7 articles
A retraction of this article was approved in:
Retraction: COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction
Citation: Wen Z, Sun J, Luo J, Fu Y, Qiu Y, Li Y, Xu Y, Wu H and Zhang Q (2022) COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction. Front. Oncol. 12:1049345. doi: 10.3389/fonc.2022.1049345
Received: 20 September 2022; Accepted: 10 November 2022;
Published: 30 November 2022; Retracted: 10 December 2024.
Edited by:
Sumit Sahni, Royal North Shore Hospital, AustraliaReviewed by:
Sean Porazinski, The Kinghorn Cancer Centre, AustraliaDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.